Silo Pharma, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SILO research report →
Companysilopharma.com
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases.
- CEO
- Eric Weisblum
- IPO
- 2021
- Employees
- 3
- HQ
- Sarasota, FL, US
Price Chart
Valuation
- Market Cap
- $2.98M
- P/E
- -1.05
- P/S
- 41.39
- P/B
- 0.90
- EV/EBITDA
- 0.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -328.69%
- Op Margin
- -6631.16%
- Net Margin
- -6717.40%
- ROE
- -88.41%
- ROIC
- -75.73%
Growth & Income
- Revenue
- $72.10K · 0.00%
- Net Income
- $-4,227,698 · 3.76%
- EPS
- $-0.50 · 57.98%
- Op Income
- $-4,280,662
- FCF YoY
- -21.58%
Performance & Tape
- 52W High
- $1.01
- 52W Low
- $0.22
- 50D MA
- $0.41
- 200D MA
- $0.48
- Beta
- 0.78
- Avg Volume
- 4.97M
Get TickerSpark's AI analysis on SILO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 15, 25 | Weisblum Eric | buy | 2,500 |
| Dec 15, 25 | Weisblum Eric | buy | 2,500 |
| Nov 21, 25 | Weisblum Eric | buy | 1,000 |
| Nov 20, 25 | Weisblum Eric | buy | 1,000 |
| Nov 19, 25 | Weisblum Eric | buy | 4,500 |
| Nov 18, 25 | Weisblum Eric | buy | 7,500 |
| May 27, 25 | Weisblum Eric | buy | 10,000 |
| May 23, 25 | Linsley Wayne | other | 50,000 |
| May 23, 25 | Munoz Kevin | other | 50,000 |
| May 23, 25 | Ryweck Daniel E. | other | 50,000 |
Our SILO Coverage
We haven't published any research on SILO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SILO Report →